Vanguard Portfolio Management Acquires 6.38% Stake in Pacira BioSciences Inc (PCRX)

On May 1, 2026, Vanguard Portfolio Management LLC filed a Schedule 13G with the SEC, reporting a new ownership stake in Pacira BioSciences Inc (PCRX). As of the event date on March 31, 2026, the investment adviser beneficially owns 2,585,964 shares of Common Stock, representing a 6.38% ownership interest in the company. According to the filing, Vanguard Portfolio Management exercises sole dispositive power over all 2,585,964 shares, while holding sole voting power over 84,678 shares. The reporting person indicated that the securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. This filing reflects the aggregate holdings of Vanguard Portfolio Management LLC and its affiliates, including Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC. Previously, the filer reported 0.0% ownership, marking this as a significant new position in the pharmaceutical company.